MedCity News January 16, 2020
Arundhati Parmar

In an interview at the J.P. Morgan Healthcare Conference in San Francisco earlier this week, the CEO of Dexcom relayed a strong desire to sell CGM systems directly to the consumers with possible pilots this year.

Kevin Sayer, Dexcom’s chairman president and CEO, was at J.P. Morgan’s annual healthcare conference in San Francisco earlier this week to present the latest financial results as well as describe what’s ahead for the company. The San Diego medical device company has emerged as the leader in the continuous glucose monitoring space.

Later, he sat down with MedCity News for an interview. One of the most notable exchanges involved his vision to bring the company’s CGM system directly to consumers.

Here is a slightly...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Conferences / Podcast, Digital Health, Patient / Consumer, Provider, Technology, Trends
Digital health venture capital deals stagnate
Finger on the Pulse: The State of Primary Care in the U.S. and Nine Other Countries
Embracing digital transformation with a digital factory
What Change Healthcare And The Postal Service Can Tell Us About The Coming Platform Revolution
Digital Health Intelligence Market Analysis: Shared Care Records - a time of transition and expansion

Share This Article